Skip to main content
PMC home page
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
. 1985 Jan 1;132(1):41–44.

Arrest of neuropathy and myopathy in abetalipoproteinemia with high-dose vitamin E therapy.

R A Hegele, A Angel
PMCID: PMC1346503  PMID: 2981135

Abstract

A 16-year-old girl, one of dizygotic twins, presented in 1976 complaining of a 1-year history of a lack of coordination and an inability to run. The results of biochemical tests confirmed the diagnosis of classic abetalipoproteinemia. In addition to the recognized neurologic features of this disorder, she had a reduced evoked motor unit potential and markedly elevated serum levels of muscle enzymes, which suggested myositis. The serum vitamin E level was markedly decreased. Oral therapy with vitamin E, 800 mg daily, was begun, and in 1981 the dosage was increased to 3200 mg daily. Over the 7 years of follow-up she improved clinically, there was an increase in the evoked motor unit potential, the serum levels of some of the muscle enzymes decreased to normal, and the serum and tissue vitamin E levels increased significantly. It was concluded that treatment with high doses of vitamin E was responsible for the arrest of the usually progressive neuropathy and myopathy.

Full text

PDF
41

Images in this article

41Fig. 1
on p.41
43Fig. 3
on p.43

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Azizi E., Zaidman J. L., Eshchar J., Szeinberg A. Abetalipoproteinemia treated with parenteral and oral vitamins A and E, and with medium chain triglycerides. Acta Paediatr Scand. 1978 Nov;67(6):796–801. doi: 10.1111/j.1651-2227.1978.tb16264.x. [DOI] [PubMed] [Google Scholar]
  2. BASSEN F. A., KORNZWEIG A. L. Malformation of the erythrocytes in a case of atypical retinitis pigmentosa. Blood. 1950 Apr;5(4):381–387. [PubMed] [Google Scholar]
  3. Bieri J. G., Hoeg J. M., Schaefer E. J., Zech L. A., Brewer H. B., Jr Vitamin A and vitamin E replacement in abetalipoproteinemia. Ann Intern Med. 1984 Feb;100(2):238–239. doi: 10.7326/0003-4819-100-2-238. [DOI] [PubMed] [Google Scholar]
  4. Diplock A. T. The biological function of vitamin E and the nature of the interaction of the vitamin with selenium. World Rev Nutr Diet. 1978;31:178–183. doi: 10.1159/000401322. [DOI] [PubMed] [Google Scholar]
  5. Elias E., Muller D. P., Scott J. Association of spinocerebellar disorders with cystic fibrosis or chronic childhood cholestasis and very low serum vitamin E. Lancet. 1981 Dec 12;2(8259):1319–1321. doi: 10.1016/s0140-6736(81)91342-8. [DOI] [PubMed] [Google Scholar]
  6. Illingworth D. R., Connor W. E., Miller R. G. Abetalipoproteinemia. Report of two cases and review of therapy. Arch Neurol. 1980 Oct;37(10):659–662. doi: 10.1001/archneur.1980.00500590083015. [DOI] [PubMed] [Google Scholar]
  7. Kayden H. J. Abetalipoproteinemia. Annu Rev Med. 1972;23:285–296. doi: 10.1146/annurev.me.23.020172.001441. [DOI] [PubMed] [Google Scholar]
  8. Kayden H. J., Hatam L. J., Traber M. G. The measurement of nanograms of tocopherol from needle aspiration biopsies of adipose tissue: normal and abetalipoproteinemic subjects. J Lipid Res. 1983 May;24(5):652–656. [PubMed] [Google Scholar]
  9. Machlin L. J., Filipski R., Nelson J., Horn L. R., Brin M. Effects of a prolonged vitamin E deficiency in the rat. J Nutr. 1977 Jul;107(7):1200–1208. doi: 10.1093/jn/107.7.1200. [DOI] [PubMed] [Google Scholar]
  10. Miller R. G., Davis C. J., Illingworth D. R., Bradley W. The neuropathy of abetalipoproteinemia. Neurology. 1980 Dec;30(12):1286–1291. doi: 10.1212/wnl.30.12.1286. [DOI] [PubMed] [Google Scholar]
  11. Muller D. P., Lloyd J. K., Bird A. C. Long-term management of abetalipoproteinaemia. Possible role for vitamin E. Arch Dis Child. 1977 Mar;52(3):209–214. doi: 10.1136/adc.52.3.209. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Muller D. P., Lloyd J. K. Effect of large oral doses of vitamin E on the neurological sequelae of patients with abetalipoproteinemia. Ann N Y Acad Sci. 1982;393:133–144. doi: 10.1111/j.1749-6632.1982.tb31239.x. [DOI] [PubMed] [Google Scholar]
  13. Nelson J. S., Fitch C. D., Fischer V. W., Broun G. O., Jr, Chou A. C. Progressive neuropathologic lesions in vitamin E-deficient rhesus monkeys. J Neuropathol Exp Neurol. 1981 Mar;40(2):166–186. doi: 10.1097/00005072-198103000-00008. [DOI] [PubMed] [Google Scholar]
  14. Rosenblum J. L., Keating J. P., Prensky A. L., Nelson J. S. A progressive neurologic syndrome in children with chronic liver disease. N Engl J Med. 1981 Feb 26;304(9):503–508. doi: 10.1056/NEJM198102263040902. [DOI] [PubMed] [Google Scholar]
  15. Sokol R. J., Heubi J. E., Iannaccone S. T., Bove K. E., Balistreri W. F. Vitamin E deficiency with normal serum vitamin E concentrations in children with chronic cholestasis. N Engl J Med. 1984 May 10;310(19):1209–1212. doi: 10.1056/NEJM198405103101901. [DOI] [PubMed] [Google Scholar]
  16. Sung J. H., Park S. H., Mastri A. R., Warwick W. J. Axonal dystrophy in the gracile nucleus in congenital biliary atresia and cystic fibrosis (mucoviscidosis): beneficial effect of vitamin E therapy. J Neuropathol Exp Neurol. 1980 Sep;39(5):584–597. doi: 10.1097/00005072-198009000-00007. [DOI] [PubMed] [Google Scholar]
  17. Tomasi L. G. Reversibility of human myopathy caused by vitamin E deficiency. Neurology. 1979 Aug;29(8):1182–1186. doi: 10.1212/wnl.29.8.1182. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES